Alnylam Pharmaceuticals | ALNY - EPS Earnings Per Share



Alnylam Pharmaceuticals reported $0.32 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.27 -0.50 Oct/23 2025
FY2025Q2 Jun/2025 0.32 -0.73 0.56 Jul/31 2025
FY2025Q1 Mar/2025 -0.01 -0.94 -0.16 May/01 2025
FY2024Q4 Dec/2024 0.06 -0.58 -0.77 Feb/13 2025
FY2024Q3 Sep/2024 -0.50 -0.93 1.74 Oct/31 2024
FY2024Q2 Jun/2024 0.56 -1.05 -2.21 Aug/01 2024
FY2024Q1 Mar/2024 -0.16 -1.14 -1.4 May/02 2024
FY2023Q4 Dec/2023 -0.77 -1.26 -1.68 Feb/15 2024
FY2023Q3 Sep/2023 1.74 -1.32 -2.69 Nov/02 2023
FY2023Q2 Jun/2023 -2.21 -1.50 -2.29 Aug/03 2023
FY2023Q1 Mar/2023 -1.40 -1.79 -2.00 May/04 2023
FY2022Q4 Dec/2022 -1.68 -1.95 -2.16 Feb/23 2023


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Arrowhead Research USD -1.26 4.01 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
Novartis USD 2.06 0.08 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Sanofi USD 1.66 0.9 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Takeda JPY 79.4 145.4 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025
Xencor USD -0.41 0.25 Jun/2025